- Home
- / Kangstem Biotech
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Kangstem Biotech financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
₩2.1 K
2024-10-29
Market Capitalization
₩114.9 B
2024-10-29
Revenue
₩7.7 B
FY, 2024
CreditSafe Score
?
Score changed on Jun 06, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| KRW | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 9.2B | 6.0B | 9.1B | 12.4B | 16.3B | 12.7B | 7.7B |
| Cost of goods sold | 6.6B | 7.0B | 7.3B | 8.1B | 7.7B | 7.9B | 838.6M |
| Gross profit | 2.9B | 1.8B | 2.0B | 5.7B | 9.1B | 4.8B | 7.1B |
| Gross profit margin, % | 30.5% | 22.2% | 46.2% | 55.5% | 37.9% | 91.1% | |
| Operating expense total | 13.0B | 21.0B | 18.4B | 24.0B | 25.9B | 24.3B | 19.1B |
| Depreciation and amortization | 1.7B | 5.9B | 3.9B | 3.1B | 3.2B | 3.4B | 2.6B |
| EBITDA | (10.8B) | (19.7B) | (16.4B) | (18.2B) | (16.9B) | (20.2B) | (4.7B) |
| EBITDA margin, % | -328.3% | -179.6% | -147.1% | -103.6% | -159.1% | -60.8% | |
| EBIT | (13.3B) | (25.7B) | (20.4B) | (21.4B) | (20.4B) | (23.7B) | (7.3B) |
| EBIT margin, % | -427.3% | -222.8% | -172.8% | -125.2% | -186.7% | -94.7% | |
| Interest income | 186.4M | 426.1M | 874.1M | 742.1M | 1.2B | 1.5B | 1.5B |
| Interest expense | 949.9M | 1.1B | 560.7M | 761.1M | 761.1M | 893.4M | 425.9M |
| Pre tax profit | (14.1B) | (26.3B) | (19.8B) | (21.8B) | (20.2B) | (23.1B) | (7.1B) |
| Income tax expense | 230.6M | 92.3M | (10.0M) | 15.8M | (39.0M) | 83.7M | |
| Net Income | (14.3B) | (26.4B) | (19.7B) | (21.8B) | (20.2B) | (23.2B) | (7.1B) |